Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alfred E.R. Arnold
Increased Serum Levels of Fibrinogen Degradation Products Due to Treatment With Recombinant Tissue-Type Plasminogen Activator for Acute Myocardial Infarction Are Related to Bleeding Complications, but Not to Coronary Patency
Journal of the American College of Cardiology
Cardiovascular Medicine
Cardiology
Acute Coronary Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator: Initial Patency and Influence of Maintained Infusion on Reocclusion Rate
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Related publications
Ventricular Arrhythmias During Treatment With Alteplase (Recombinant Tissue Plasminogen Activator) in Suspected Acute Myocardial Infarction.
Heart
Cardiovascular Medicine
Cardiology
Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction.
BMJ
Acute Myocardial Infarction Due to Coronary Dissection in Early Postpartum
Cor et Vasa
Cardiovascular Medicine
Cardiology
Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke Can Cause Inferior Myocardial Infarction?
Neurology International
Neurology
Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction: Authors' Reply
BMJ
Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke
Case Reports in Critical Care
Soluble HLA-DR Serum Levels Are Associated With Smoking but Not With Acute Coronary Syndrome
Atherosclerosis
Cardiovascular Medicine
Cardiology
Intravenous and Intrapulmonary Recombinant Tissue-Type Plasminogen Activator in the Treatment of Acute Massive Pulmonary Embolism
Circulation
Cardiovascular Medicine
Physiology
Cardiology
